GSK | ||
---|---|---|
OUTLOOK RATING 1..100 | 86 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 8 Undervalued | |
PROFIT vs RISK RATING 1..100 | 53 | |
SMR RATING 1..100 | 40 | |
PRICE GROWTH RATING 1..100 | 46 | |
P/E GROWTH RATING 1..100 | 14 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
EFAV | GSK | |
---|---|---|
RSI ODDS (%) | 2 days ago90% | 2 days ago50% |
Stochastic ODDS (%) | 2 days ago64% | 2 days ago36% |
Momentum ODDS (%) | 2 days ago79% | 2 days ago61% |
MACD ODDS (%) | 2 days ago67% | 2 days ago67% |
TrendWeek ODDS (%) | 2 days ago78% | 2 days ago61% |
TrendMonth ODDS (%) | 2 days ago74% | 2 days ago53% |
Advances ODDS (%) | 4 days ago77% | 4 days ago59% |
Declines ODDS (%) | 10 days ago77% | 2 days ago52% |
BollingerBands ODDS (%) | 2 days ago77% | 2 days ago48% |
Aroon ODDS (%) | 2 days ago72% | 2 days ago48% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
EZJ | 50.58 | 1.80 | +3.69% |
ProShares Ultra MSCI Japan | |||
JOF | 10.74 | 0.11 | +1.03% |
Japan Smaller Capitalization Fund | |||
HYLS | 42.08 | 0.03 | +0.07% |
First Trust Tactical High Yield ETF | |||
IBTQ | 25.52 | -0.06 | -0.23% |
iShares iBonds Dec 2035 Term Trsy ETF | |||
AMUB | 18.41 | -0.16 | -0.86% |
UBS ETRACS Alerian MLP ETN Series B |
A.I.dvisor indicates that over the last year, EFAV has been loosely correlated with HLN. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if EFAV jumps, then HLN could also see price increases.
Ticker / NAME | Correlation To EFAV | 1D Price Change % | ||
---|---|---|---|---|
EFAV | 100% | +0.52% | ||
HLN - EFAV | 64% Loosely correlated | +0.79% | ||
TEF - EFAV | 57% Loosely correlated | -0.20% | ||
GSK - EFAV | 56% Loosely correlated | -0.78% | ||
SAN - EFAV | 54% Loosely correlated | +1.28% | ||
AZN - EFAV | 54% Loosely correlated | +1.98% | ||
More |